Newsfeed
- Anika to Issue First-Quarter 2019 Financial Results and Business Highlights on Thursday, May 2
- Ironwood Pharmaceuticals to Host First Quarter 2019 Investor Update Call
- Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Paragonix Initiates Global Post Market Registry Evaluating Clinical Outcomes in Patients who Receive Donor Hearts Transported with Paragonix SherpaPak™ Cardiac Transport System
- TIE Kinetix presents the FLOW “Spring Release”
- Xerox Plans Webcast to Discuss 2019 First-Quarter Results
- The CMO of People: Workforce Institute Radio Examines Treating Employees Like Customers
- 128 Technology Expands Leadership Position in Germany by Partnering with nicos AG
- Bitfarms Announces Drawdown of US$5M Second Tranche of Loan Financing
- Care.com to Announce First Quarter 2019 Earnings Results on May 9, 2019
- New Security Innovations from Xerox Help Businesses Address Network Threats in Real Time
- Obsidian Therapeutics Announces Leadership Transition and Appoints Paul K. Wotton, Ph.D., as Chief Executive Officer
- Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of Small-Molecule Medicines Targeting RNA
- Aspen Technology Appoints Georgia Keresty PhD, MPH to Its Board of Directors
- Talaris Therapeutics, Inc. Announces Promising Phase 2 Data of Novel, Allogeneic Cell Therapy in Living Donor Kidney Transplant Recipients
